-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Health Services
-
LGBT Cancer Survivors and Disparities-Related Barriers That May Affect Survival
Cancer survivors who are lesbian, gay, bisexual, or transgender (LGBT) face potentially survival-limiting health disparities, and this should be addressed by the healthcare system. Those were the findings of a cross-sectional study comparing the health challenges of LGBT cancer survivors with those of survivors in the general population. Researchers hope the work will push providers…
-
Addressing Lung Cancer Screening Disparities in the LGBT Community
Historically, sexual minorities have been underserved in the healthcare setting. Members of this patient population may be less likely to receive optimal care, especially when it comes to preventive care such as lung cancer screening—a topic that was discussed during the Mini Oral Abstract Session “MA04: Health Policy and the Real World.” The older (between…
-
Study Identifies Lung Cancer Areas of Improvement Across Asia-Pacific Region
Lung cancer prevention and treatment remains a challenge across the Asia-Pacific region, and each country has areas where they could improve, according to a study presented during the Day 2 mini oral session, “MA04: Health Policy and the Real World.” Lung cancer is the leading cause of cancer mortality in the Asia-Pacific region accounting for…
-
Examining Value and Access in Lung Cancer Care, From Screening to Treatment
Appropriate and swift diagnosis and treatment are crucial for patients with lung cancer but can be elusive for many due to cost, healthcare disparities, and other barriers. Factors such as age, gender, and ethnicity can affect not only access to screening and care but also disease outcomes, as can the economic resources and quality of…